Skip to main content
Log in

Cilostazol Determination by the Enhancement of the Green Emission of Tb3+ Optical Sensor

  • Original Paper
  • Published:
Journal of Fluorescence Aims and scope Submit manuscript

Abstract

The efficiency of excited-state interaction between Tb3+ and the industrial product Cilostazol (CIL) has been studied in different solvents. High luminescence intensity peak at 545 nm of terbium complex in acetonitrile was obtained. The photophysical properties of the green emissive Tb3+ complex have been elucidated, the terbium was used as optical sensor for the assessment of CIL in the pharmaceutical tablets and body fluids at pH 3.1 and λex = 320 nm with a concentration range 1.0 × 10−9–1.0 × 10−6 mol L−1 of CIL, correlation coefficient of 0.998 and detection limit of 7.5 × 10−10 mol L−1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Hashiguchi M, Ohna K, Nakasawa R, Kishino S, Mochizuki M, Shiga T (2004) Comparison of CIL and ticlopidine for one-month effectiveness and safety after elective coronary stenting. Cardiovasc Drugs Ther 18:211–217

    Article  PubMed  CAS  Google Scholar 

  2. Sweet man SC (ed) (2002) In: Martinadale: the complete drug reference, 33 rd edn. Pharmaceutical Press, USA. vol I, pp 258–860

  3. Kishida M, Watanabe K, Tsuruoka T (2001) Effects of cilostazal in patients with bradycardiac arterial fibrillation. J Cardiol 37:27–33

    PubMed  CAS  Google Scholar 

  4. Madias JE (2003) CIL: an “intermittent claudicatio” remedy for management of third degree AV block. Chest 123(4):979–982

    Article  PubMed  Google Scholar 

  5. Tata PNV, Fu CJ, Browder NJ, Chow PC, Bramer SL (1998) The quantitative determination of CIL and its four metabolites in human liver microsomal incubation mixtures by high-performance liquid chromatography. J Pharm Biomed Anal 18(3):441–451

    Article  PubMed  CAS  Google Scholar 

  6. Fu CJ, Tata PNV, Okada K, Akiyama H, Bramer SL (1999) Effect of renal impairment on the pharmacokinetics of CIL and its metabolites. J Chromatogr B Biomed Appl 728:251–262

    Article  CAS  Google Scholar 

  7. Tata PNV, Fu CJ, Bramer SL (2001) Determination of CIL and its metabolites in human urine by high performance liquid chromatography. J Pharm Biomed Anal 24:381–389

    Article  PubMed  CAS  Google Scholar 

  8. Bramer SL, Tata PNV, Vengurlekar SS, Brisson JH (2001) Method for the quantitative analysis of CIL and its metabolites in human plasma using LC/MS/MS. J Pharm Biomed Anal 26:637–650

    Article  PubMed  CAS  Google Scholar 

  9. Yeon KJ, Park YJ, Park KM, Ban E, Kim YB, Kim CK (2005) Validated stability-indicating methods for determination of CIL in the presence of its degradation products according to the ICH guidelines. J Liq Chromatogr Relat Technol 28:109–120

    Article  CAS  Google Scholar 

  10. Fayed AS, Shehata MA, Ashour A, Hassan NY, Weshahy SA (2007) Validated stability-indicating methods for determination of CIL in the presence of its degradation products according to the ICH guidelines. J Pharm Biomed Anal 45:407–416

    Article  PubMed  CAS  Google Scholar 

  11. Kanthi Kiran VS Varanasi, Sridhar V, Suresh Potharaju, Shraddha R, Sivakumar SPN, Kanaga Sabapathi S, Satheeshmanikandan TRS, Swaroop Kumar VVS (2008) Development and validation of a liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of nateglinide, cilostazol and its active metabolite 3,4-dehydro-cilostazol in Wistar rat plasma and its application to pharmacokinetic study. J Chromatogr B 865(1–2):91–98

  12. Al-Arfaj NA (2004) Flow-injection chemiluminescent determination of metoclopramide hydrochloride in pharmaceutical formulations and biological fluids using the [Ru(dipy)2+]–permanganate system. Talanta 62:255–263

    Article  PubMed  CAS  Google Scholar 

  13. Attia MS (2009) Spectrofluorimetric quantification of bromazepam using a highly selective optical probe based on Eu3 + bromazepam complex in pharmaceutical and serum samples. Spectrochim Acta Part A 74:972–976

    Article  CAS  Google Scholar 

  14. Attia MS (2010) Spectrofluorimetric assessment of Ramipril using optical sensor Samarium ion–doxycycline complex doped in sol–gel matrix. J Pharm Biomed Anal 51:7–11

    Article  PubMed  CAS  Google Scholar 

  15. Attia MS, Othman AM, Aboaly MM, Abdel-Mottaleb MSA (2010) Novel spectrofluorimetric method for measuring the activity of the enzyme r-L-Fucosidase using the nano composite optical sensor Samarium(III)-Doxycycline complex doped in Sol-Gel matrix. Anal Chem 82(14):6230–6236

    Article  PubMed  CAS  Google Scholar 

  16. International Conference on Hormonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1). Current Step 4 version Parent Guideline dated 27 October 1994 (Complementary Guideline on Methodology dated 6 November 1996 incorporated in November 2005)

  17. (1999) British pharmacopoeia, vol. II, Her majesty’s stationary office. London, p. 2705

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. S. Attia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Attia, M.S., Mahmoud, W.H., Youssef, A.O. et al. Cilostazol Determination by the Enhancement of the Green Emission of Tb3+ Optical Sensor. J Fluoresc 21, 2229–2235 (2011). https://doi.org/10.1007/s10895-011-0927-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10895-011-0927-y

Keywords

Navigation